SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BERNARDI, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 31.518
AS - Asia 14.971
EU - Europa 9.313
SA - Sud America 2.491
AF - Africa 247
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 58.592
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 30.866
SG - Singapore 6.089
CN - Cina 4.380
BR - Brasile 2.106
DE - Germania 2.027
UA - Ucraina 1.735
IT - Italia 1.603
HK - Hong Kong 1.425
TR - Turchia 1.083
GB - Regno Unito 967
VN - Vietnam 916
FI - Finlandia 597
PL - Polonia 549
SE - Svezia 489
RU - Federazione Russa 471
CA - Canada 304
MX - Messico 282
ID - Indonesia 225
FR - Francia 205
IN - India 205
AR - Argentina 152
NL - Olanda 130
JP - Giappone 129
ZA - Sudafrica 121
ES - Italia 113
BD - Bangladesh 108
BE - Belgio 103
EC - Ecuador 66
CZ - Repubblica Ceca 63
IQ - Iraq 60
AT - Austria 53
LT - Lituania 48
IR - Iran 40
UZ - Uzbekistan 37
CO - Colombia 36
MA - Marocco 34
VE - Venezuela 34
PK - Pakistan 32
AU - Australia 26
CL - Cile 25
PE - Perù 25
CH - Svizzera 24
JO - Giordania 22
KE - Kenya 22
IL - Israele 21
MY - Malesia 21
PY - Paraguay 21
IE - Irlanda 20
AE - Emirati Arabi Uniti 18
UY - Uruguay 18
RO - Romania 17
SA - Arabia Saudita 17
TW - Taiwan 16
AZ - Azerbaigian 15
AL - Albania 14
KR - Corea 14
DZ - Algeria 13
PT - Portogallo 13
TN - Tunisia 13
EU - Europa 12
GR - Grecia 12
JM - Giamaica 12
NP - Nepal 12
EG - Egitto 11
BG - Bulgaria 10
KZ - Kazakistan 10
DO - Repubblica Dominicana 9
GE - Georgia 9
SN - Senegal 8
CR - Costa Rica 7
HN - Honduras 7
KW - Kuwait 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
OM - Oman 7
TH - Thailandia 7
BY - Bielorussia 6
DK - Danimarca 6
GT - Guatemala 6
AF - Afghanistan, Repubblica islamica di 5
BH - Bahrain 5
BO - Bolivia 5
HU - Ungheria 5
KG - Kirghizistan 5
LB - Libano 5
NG - Nigeria 5
NI - Nicaragua 5
PH - Filippine 5
TT - Trinidad e Tobago 5
CI - Costa d'Avorio 4
MK - Macedonia 4
PA - Panama 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BW - Botswana 3
GA - Gabon 3
KH - Cambogia 3
LK - Sri Lanka 3
Totale 58.539
Salva come PNG Salva come JPEG
Città #
Singapore 3.448
Woodbridge 2.988
Fairfield 2.928
Ashburn 2.793
Chandler 1.929
Houston 1.913
Jacksonville 1.837
Santa Clara 1.550
Beijing 1.413
Hong Kong 1.408
Ann Arbor 1.407
Seattle 1.207
Wilmington 1.110
Cambridge 962
Dallas 904
Izmir 629
Nanjing 571
New York 549
Warsaw 531
Ferrara 522
Munich 517
Los Angeles 494
Princeton 437
Boardman 405
Ho Chi Minh City 321
San Diego 272
The Dalles 221
Milan 214
Shanghai 205
São Paulo 202
Mexico City 192
Hanoi 183
Dearborn 173
Nanchang 173
Shenyang 170
Jakarta 163
Bremen 162
Helsinki 144
London 140
Tianjin 136
Buffalo 121
Hebei 120
Chicago 118
Hefei 112
Brooklyn 110
Jiaxing 110
Tokyo 110
Falls Church 104
Toronto 100
Turku 99
Changsha 98
Orem 97
Brussels 94
Montreal 92
Redwood City 86
Denver 85
Jinan 82
Johannesburg 76
Falkenstein 75
Frankfurt am Main 74
Moscow 73
Norwalk 72
San Mateo 71
Chennai 70
Rio de Janeiro 68
Kunming 67
Stockholm 66
Mountain View 65
Atlanta 62
Council Bluffs 59
Phoenix 59
Rome 58
Düsseldorf 57
Poplar 56
San Jose 56
Belo Horizonte 51
San Francisco 51
Zhengzhou 50
Auburn Hills 49
Brno 48
Guangzhou 48
Manchester 48
Nuremberg 47
Curitiba 45
Amsterdam 44
Boston 44
Dong Ket 44
Addison 42
Des Moines 41
Ningbo 38
Hangzhou 37
Brasília 36
Ankara 34
Columbus 34
Bologna 33
Da Nang 33
Haiphong 32
Orange 31
Tashkent 31
Ottawa 30
Totale 39.466
Salva come PNG Salva come JPEG
Nome #
Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System 376
C6orf10 low-frequency and rare variants in italian multiple sclerosis patients 292
Are Plasma Levels of Vascular Adhesion Protein-1 Associated Both with Cerebral Microbleeds in Multiple Sclerosis and Intracerebral Haemorrhages in Stroke? 280
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 265
AN EXON-SPECIFIC U1 SMALL NUCLEAR RNA (snRNA) STRATEGY TO CORRECT SPLICING MUTATIONS ASSOCIATED TO HEMOPHILIA B 263
Ricerche metodologiche sul dosaggio del cofattore Ristocetinico per la diagnosi di morbo di von Willebrand. 260
Regulation of a strong F9 cryptic 5'ss by intrinsic elements and by combination of tailored U1snRNAs with antisense oligonucleotides 252
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes 250
Activated factor VII-antithrombin complex predicts mortality in patients with stable coronary artery disease: a cohort study 248
An exon-specific U1snRNA induces a robust factor IX activity in mice expressing multiple human FIX splicing mutants 247
Exploring Splicing-Switching Molecules For Seckel Syndrome Therapy 242
An integrated genomic-transcriptomic approach supports a role for the proto-oncogene BCL3 in atherosclerosis 242
Hemostasis biomarkers in multiple sclerosis 231
Analisi dei multimeri del fattore von Willebrand mediante doppia immunoprecipitazione dopo elettroforesi su gel di agarosio. 226
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 225
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 225
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 223
A frequent human coagulation Factor VII mutation (A294V, c152) in loop 140s affects the interaction with activators, tissue factor and substrates 218
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family 217
High-density lipoprotein cholesterol is associated with multiple sclerosis fatigue: A fatigue-metabolism nexus? 215
A De Novo and Heterozygous Gene Deletion Causing a Variant of von Willebrand Disease 213
Stimulation of P2 (P2X7) receptors in human dendritic cells induces the release of tissue factor-bearing microparticles. 211
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 211
Characterization of a deleted Y chromosome in a male with Turner stigmata 210
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 208
A novel mutation (Leu817Pro) causing type 2A von Willebrand disease 208
A heparin cofactor II mutation (HCII Rimini) combined with factor V Leiden or type I protein C deficiency in two unrelated thrombophilic subjects 207
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 207
A NEW DISEASE-CAUSING MUTATION IN THE GAP-RELATED DOMAIN OF THE NF1 GENE 205
A factor V genetic component differing from factor V R506Q contributes to the activated protein C resistance phenotype 205
Activation of a cryptic splice site in a potentially lethal coagulation defect accounts for a functional protein variant 205
Calmodulin expression distinguishes the smooth muscle cell population of human carotid plaque 203
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 202
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 202
Angiotensin-converting enzyme insertion/deletion polymorphism and risk of restenosis after directional coronary atherectomy followed by stent implantation 200
Moderate alcohol intake and hemostatic and inflammatory markers in middle-aged women: a controlled study 200
U1snRNA-mediated rescue of mRNA processing in severe factor VII deficiency 198
Genetic determinants of activated factor VII antithrombin complex plasma concentration include tissue factor, factor VII and endothelial protein C receptor gene variants 197
Chronic sleep deprivation markedly reduces coagulation factor VII expression 196
A DE NOVO GENE ALTERATION CAUSING VON WILLEBRAND DISEASE 194
Attività sulla emostasi di alcune piante della medicina tradizionale indiana 194
A "de novo" Gene Deletion and New RFLPs Detected by von Willebrand Factor cDNA. 194
An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects 191
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 191
Psychiatric disorder in a familial 15;18 translocation and sublocalization of myelin basic protein of 18q22.3 189
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene cluster 188
Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile 188
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency 188
Factor II Activity is Similarly Increased in Patients With Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 186
TRATTAMENTO E PREVENZIONE DI MALATTIE CARDIOVASCOLARI CON ACIDO ERUCICO E METODI DIAGNOSTICI CORRELATI 185
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 184
The carboxyl-terminal region is NOT essential for secreted and functional levels of coagulation factor X 184
Tailoring the CRISPR system to transactivate coagulation gene promoters in normal and mutated contexts 184
Molecular bases of type II protein S deficiency: the I203-D204 deletion in the EGF4 domain alters GLA domain function 182
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 182
Evidence for an overlapping role of clock and npas2 transcription factors in liver circadian oscillators 181
The effectiveness of Robot-Assisted Gait Training versus conventional therapy on mobility in severely disabled progressIve MultiplE sclerosis patients (RAGTIME): Study protocol for a randomized controlled trial 181
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene 181
Membrane binding and anticoagulant properties of protein S natural variants 180
A unique exon specific U1snRNA rescues different haemophilia B - causing splicing-defective factor IX variants in mice 180
The carboxyl-terminal region is not essential for secreted and functional levels of coagulation factor X 180
A missense mutation (Y1702C) in the coagulation factor V gene is a frequent cause of factor V deficiency in the italian population 179
Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity 179
c-myc oncogene alterations in human thyroid carcinomas. 179
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease 177
FV multiallelic marker detects genetic components of APC resistance contributing to venous thromboembolism in FV Leiden carriers 176
FXIII levels and genotypes in myocardial infarction: a potential novel prognostic biomarker? 176
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 176
Molecular bases of CRM+ factor X deficiency: a frequent mutation (Ser334Pro) in the catalytic domain and a substitution (Glul02Lys) in the second EGF‐like domain 175
The dominant-negative von Willebrand factor gene deletion p.P1127-C1948delinsR: Molecular mechanism and modulation 175
A new factor V gene polymorphism (His 1254 Arg) present in subjects of African origin mimics the R2 polymorphism (His 1299 Arg) 174
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 174
The factor V Glu1608Lys mutation is recurrent in familial thrombophilia 173
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis 172
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 172
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations 171
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 170
Organization of α-Globin Genes and mRNA Translation in Subjects Carrying Haemoglobin Hasharon (α47 Asp → His) from the Ferrara Region (Northern Italy) 169
Circadian rhythms in mouse blood coagulation 168
Temporal variations of coagulation factor VII activity in mice are influenced by lighting regime 167
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency 167
PvuII RFLP inside the human estrogen receptor gene 167
Plasma levels of soluble NCAM in multiple sclerosis 167
Residual factor VII activity and different hemorrhagic phenotypes in CRM+ factor VII deficiencies (Gly331Ser and Gly283Ser) 166
Mutations in the R2 FV gene affect the ratio between the two FV isoforms in plasma 166
Deletion of exons 26-34 (domain D3-A3) of von Willebrand-factor gene in the von Willebrand disease type-II. 166
The F11 rs2289252 polymorphism is associated with FXI activity levels and APTT ratio in women with thrombosis 166
Correction of aberrant splicing causing haemophilia B through the combination of compensatory U1snRNAs and antisense oligonucleotides 165
Asymmetric processing of mutant factor X Arg386Cys reveals differences between intrinsic and extrinsic pathway activation 165
Human protein S circulates in plasma partially bund to LDL and HDL: do PS-lipoprotein complexes mediate PS delivery within atherosclerotic plaque? 162
Performance prediction models based on anthropometric, genetic and psychological traits of Croatian sprinters 162
Characterization and mapping of the 5′ portion of von Willebrand factor pseudogene 161
Factor VII mutant V154G models a zymogen-like form of factor VIIa 161
A novel factor V null mutation detected in a thrombophilic patient with pseudo-homozygous APC resistance and in an asymptomatic unrelated subject 161
A family study of FVII genotype, elevated levels of factor VII and arterial thrombotic disease 161
Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele 161
Rapid detection of a protein C gene mutation present in the asymptomatic and not in the thrombosis‐prone lineage 160
Partial gene deletion in a family with factor X deficiency 160
An Italian Family with a Novel Mutation Causing Type 2A von Willebrand Disease and with Reduced Levels of von Willebrand Factor not Linked with the von Willebrand Factor Gene. 160
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency 159
Totale 19.537
Salva come PNG Salva come JPEG
Categoria #
all - tutte 280.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.809
Totale 282.162
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.465 0 0 0 0 0 500 331 627 180 801 735 291
2021/20224.434 245 482 276 246 261 178 206 211 138 344 391 1.456
2022/20234.440 488 342 109 583 726 661 211 356 543 39 244 138
2023/20242.348 203 277 110 81 166 433 65 154 59 56 64 680
2024/20259.468 266 186 817 272 1.175 920 242 468 1.492 1.197 1.356 1.077
2025/202615.559 2.588 1.191 2.610 3.726 4.020 1.424 0 0 0 0 0 0
Totale 59.297